NCT05050877View on ClinicalTrials.gov

Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II

CompletedOBSERVATIONAL
Enrollment

184,855

Participants

Timeline

Start Date

June 1, 2000

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Cardio-Renal SyndromeCoronary AngiographyCoronary Artery DiseaseKidney DiseasesMetabolic Syndrome
Trial Locations (1)

510080

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
collaborator

First Affiliated Hospital of Fujian Medical University

OTHER

collaborator

Maoming Hospital Affiliated to Southern Medical University

UNKNOWN

collaborator

Shenzhen People's Hospital

OTHER

collaborator

Yangjiang People's Hospital

OTHER

lead

Guangdong Provincial People's Hospital

OTHER

NCT05050877 - Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II | Biotech Hunter | Biotech Hunter